DLL4, Human (Demcizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-DLL4, Human (Demcizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityDLL4, Human (Demcizumab biosimilar)
CloneDemcizumab
Host SpeciesRecombinant Mouse
Reactive Specieshuman
IsotypeIgG2 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsELISA, FCM, IP, FuncS, IF, Neut, WB
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human DLL4 Recombinant Antibody (Demcizumab). Demcizumab /d m s z maeb/ is a humanized monoclonal antibody which is used to treat patients with pancreatic cancer or non-small cell lung cancer. Demcizumab has completed phase 1 trials and is currently undergoing phase 2 trials. Demcizumab was developed by OncoMed Pharmaceuticals in collaboration with Celgene.
Immunogenn/a
Other NamesAnti-DLL4 Recombinant Antibody, Research Grade Demcizumab, Anti-Human DLL4 Recombinant Antibody(Demcizumab), OMP-21M18, Antibody Drug Analogues, Monoclonal Antibody, YR1276, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1243262-17-0
Catalog #YR1276
Priceplease inquire
Order / More InfoDLL4, Human (Demcizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.